Skip to content
value.today

StrideBio, Inc.

🇺🇸 Durham, North Carolina, USABiotechnologyFounded 2015

Formerly StrideBio, LLC, Stride Therapeutics LLC

Total raised
$58 M
3 rounds on record
Latest round
$49 M
Mar 2021
First round on record
May 2017
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of StrideBio, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2021$49 MNo. 3$10 to $50 million

StrideBio, Inc.: Raise no. 3, Mar 2021

Investors in this round

17 investors had bought by the notice of Mar 26, 2021: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$49 M of $82 M offered; $33 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Offer and sale of shares of preferred stock and the underlying shares of common stock issuable upon conversion thereof.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Maritza McIntyre · Executive Officer
  • Robert Hughes · Executive Officer
  • Sapan Shah · Executive Officer, Director
  • William Monteith · Executive Officer
  • Aravind Asokan · Director
  • Clay Thorp · Director
  • Erica Whittaker · Director
  • Karen Hong · Director
  • Michael Martin · Director
  • Shaan Gandhi · Director
  • Stewart Parker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Hughes, Senior Vice President, Finance and Administration. Source: SEC Form D, newest notice filed Mar 26, 2021. Read the notice at the SEC.

equitySEC
Jun 2018$8 MNo. 2$2 to $10 million

StrideBio, Inc.: Raise no. 2, Jun 2018

Investors in this round

12 investors had bought by the notice of Jun 18, 2018: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $16 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Patrick Ritschel · Executive Officer, Director, Promoter
  • Richard Smith · Executive Officer
  • Aravind Asokan · Director, Promoter
  • Clay Thorp · Director
  • Mavis Agbandje-McKenna · Director, Promoter
  • Mike Dial · Director
  • Stewart Parker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount reflects second tranche of capital commitments that are subject to the prior satisfaction of certain milestones.”

Signed by Patrick Ritschel, President. Source: SEC Form D, newest notice filed Jun 18, 2018. Read the notice at the SEC.

equitySEC
May 2017$1 MNo. 1Under $2 million

StrideBio, Inc.: Raise no. 1, May 2017

Investors in this round

3 investors had bought by the notice of Jun 5, 2017: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$90,000
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Patrick Ritschel · Executive Officer, Director, Promoter
  • Richard Smith · Executive Officer
  • Aravind Asokan · Director
  • Mavis Abjandje-McKenna · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Patrick Ritschel, President. Source: SEC Form D, newest notice filed Jun 5, 2017. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • StrideBio, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2021).

    SEC Form D · Mar 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2021

That is all the official record says: StrideBio, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of StrideBio, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 17 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by StrideBio, Inc.
NameRoleNamed in
Maritza McIntyreExecutive officerMar 2021
Robert HughesExecutive officerMar 2021
Sapan ShahExecutive officerMar 2021
William MonteithExecutive officerMar 2021
Patrick RitschelExecutive officerJun 2018
Richard SmithExecutive officerJun 2018
Aravind AsokanDirectorMar 2021
Clay ThorpDirectorMar 2021
Erica WhittakerDirectorMar 2021
Karen HongDirectorMar 2021
Michael MartinDirectorMar 2021
Sapan ShahDirectorMar 2021
Shaan GandhiDirectorMar 2021
Stewart ParkerDirectorMar 2021
Mavis Agbandje-McKennaDirectorJun 2018
Mike DialDirectorJun 2018
Patrick RitschelDirectorJun 2018
Mavis Abjandje-McKennaDirectorJun 2017
Aravind AsokanPromoterJun 2018
Mavis Agbandje-McKennaPromoterJun 2018
Patrick RitschelPromoterJun 2018